EMD Serono partners US government to widen IVF access
Merck’s healthcare division in Canada and the US, EMD Serono, has signed an agreement with the Trump administration to expand…
Women's Health
-
-
FDA approves mifepristone generic as political abortion war rages on
The US Food and Drug Administration (FDA) has approved Evita Solutions’ generic form of mifepristone, one of the two medications…
-
Biogen’s Zurzuvae approved as first postpartum depression drug in Europe
Millions of parents in Europe who suffer from postpartum depression will now have access to a pharmaceutical treatment, following the…
-
Health Canada approves AbbVie’s Elahere for ovarian cancer
Health Canada has approved AbbVie's antibody-drug conjugate (ADC), Elahere (mirvetuximab soravtansine for injection), to treat adults with certain types of…
-
MHRA approves GSK’s oral antibiotic for UTIs in females
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval to GSK's oral antibiotic pill, Blujepa (gepotidacin), for…
-
Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China
Daiichi Sankyo and AstraZeneca have received approval from China’s National Medical Products Administration (NMPA) for Datroway (datopotamab deruxtecan) to treat…
-
Gates Foundation invests $2.5bn in women’s health-focused R&D
The Gates Foundation has announced an investment of $2.5bn through to 2030, dedicated to expediting research and development (R&D) with…
-
Novartis’ ribociclib approved in Canada for early breast cancer
Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase inhibitor for the…
-
Scynexis resumes dosing in Phase III MARIO study after lengthy delay
Scynexis has resumed dosing of its vaginal yeast infection drug Brexafemme (ibrexafungerp) in a Phase III trial after a 19-month…
-
Synthetic hormones and the future of contraception
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying…
